Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women

Cancer Epidemiol Biomarkers Prev (2021) 30 (4): 643–652.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Role and recent progress of P2Y12 receptor in cancer development

Yanni Xi
Zhenya Min
Mianxue Liu
Xueqin Lin
Zhao-hua Yuan

Purinergic Signalling (2024)

Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer

Eliza Del Fiol Manna
Davide Serrano
Gaetano Aurilio
Bernardo Bonanni
Matteo Lazzeroni

Healthcare (2023) 11 (16): 2360.

The Function and Regulation of Platelet P2Y12 Receptor

Xiaohua Li
Guoxing Zhang
Xia Cao

Cardiovascular Drugs and Therapy (2023) 37 (1): 199.

Antiplatelet drugs and breast cancer risk in a large nationwide Danish case‐control study

Manon Cairat
Anton Pottegård
Morten Olesen
Laure Dossus
Agnès Fournier
Blánaid Hicks

International Journal of Cancer (2023) 152 (7): 1337.

Analgesic Use and Circulating Estrogens, Androgens, and Their Metabolites in the Women's Health Initiative Observational Study

Lauren M. Hurwitz
Aladdin H. Shadyab
Fred K. Tabung
Garnet L. Anderson
Nazmus Saquib
Robert B. Wallace
Robert A. Wild
Ruth M. Pfeiffer
Xia Xu
Britton Trabert

Cancer Prevention Research (2022) 15 (3): 173.

Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use

Teofilia Acheampong
Erica J. Lee Argov
Mary Beth Terry
Carmen B. Rodriguez
Mariangela Agovino
Ying Wei
Shweta Athilat
Parisa Tehranifar

Cancer Causes & Control (2022) 33 (3): 363.